Wouter H. van Geffen
Quick facts
Marketed products
- indacaterol/glycopyrronium 110/50 Breezhaler® · Respiratory / Pulmonology
Indacaterol is a long-acting beta-2 agonist and glycopyrronium is an anticholinergic that together relax airway smooth muscle and reduce mucus secretion to improve airflow in chronic obstructive pulmonary disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Wouter H. van Geffen
What are Wouter H. van Geffen's marketed drugs?
Top marketed products include indacaterol/glycopyrronium 110/50 Breezhaler®.
Related
- indacaterol/glycopyrronium 110/50 Breezhaler® · Respiratory / Pulmonology
- Sector hub: All tracked pharma companies